• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭合并中枢性睡眠呼吸暂停患者的研究重点。美国胸科学会官方研究声明。

Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement.

出版信息

Am J Respir Crit Care Med. 2021 Mar 15;203(6):e11-e24. doi: 10.1164/rccm.202101-0190ST.

DOI:10.1164/rccm.202101-0190ST
PMID:33719931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7958519/
Abstract

Central sleep apnea (CSA) is common among patients with heart failure and has been strongly linked to adverse outcomes. However, progress toward improving outcomes for such patients has been limited. The purpose of this official statement from the American Thoracic Society is to identify key areas to prioritize for future research regarding CSA in heart failure. An international multidisciplinary group with expertise in sleep medicine, pulmonary medicine, heart failure, clinical research, and health outcomes was convened. The group met at the American Thoracic Society 2019 International Conference to determine research priority areas. A statement summarizing the findings of the group was subsequently authored using input from all members.: The workgroup identified 11 specific research priorities in several key areas: ) control of breathing and pathophysiology leading to CSA, ) variability across individuals and over time, ) techniques to examine CSA pathogenesis and outcomes, ) impact of device and pharmacological treatment, and ) implementing CSA treatment for all individuals Advancing care for patients with CSA in the context of heart failure will require progress in the arenas of translational (basic through clinical), epidemiological, and patient-centered outcome research. Given the increasing prevalence of heart failure and its associated substantial burden to individuals, society, and the healthcare system, targeted research to improve knowledge of CSA pathogenesis and treatment is a priority.

摘要

中枢性睡眠呼吸暂停(CSA)在心力衰竭患者中较为常见,与不良结局密切相关。然而,此类患者的治疗进展一直较为有限。美国胸科学会(ATS)发布本官方声明旨在确定心力衰竭患者 CSA 相关研究的重点优先领域。一个在睡眠医学、肺病学、心力衰竭、临床研究和健康结果等领域具有专业知识的国际多学科小组应邀参与。该小组在 2019 年美国胸科学会国际会议上进行了会面,以确定研究优先领域。随后,所有小组成员共同参与,使用该会议上获得的信息,起草了一份总结小组研究结果的声明。工作组在以下几个关键领域确定了 11 项具体的研究重点:)呼吸控制和导致 CSA 的病理生理学,)个体间和随时间的变异性,)检查 CSA 发病机制和结局的技术,)设备和药物治疗的影响,以及)为所有个体实施 CSA 治疗。要在心力衰竭的背景下为 CSA 患者提供更优质的医疗服务,就需要在转化(基础到临床)、流行病学和以患者为中心的结局研究领域取得进展。鉴于心力衰竭的发病率不断上升,对个人、社会和医疗体系造成的负担也相当沉重,有针对性地开展 CSA 发病机制和治疗的研究,是当务之急。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/7958519/6aca37ac249d/rccm.202101-0190STf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/7958519/6aca37ac249d/rccm.202101-0190STf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/7958519/6aca37ac249d/rccm.202101-0190STf1.jpg

相似文献

1
Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement.心力衰竭合并中枢性睡眠呼吸暂停患者的研究重点。美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Mar 15;203(6):e11-e24. doi: 10.1164/rccm.202101-0190ST.
2
Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement.睡眠呼吸障碍病理生理学研究重点:慢性阻塞性肺疾病患者。美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2018 Feb 1;197(3):289-299. doi: 10.1164/rccm.201712-2510ST.
3
Pharmacological treatment for central sleep apnoea in adults.成人中枢性睡眠呼吸暂停的药物治疗。
Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD012922. doi: 10.1002/14651858.CD012922.pub2.
4
Prevalence and Characteristics of Central Compared to Obstructive Sleep Apnea: Analyses from the Sleep Heart Health Study Cohort.与阻塞性睡眠呼吸暂停相比,中枢性睡眠呼吸暂停的患病率及特征:来自睡眠心脏健康研究队列的分析。
Sleep. 2016 Jul 1;39(7):1353-9. doi: 10.5665/sleep.5962.
5
An Official American Thoracic Society Statement: The Importance of Healthy Sleep. Recommendations and Future Priorities.美国胸科学会官方声明:健康睡眠的重要性。建议与未来优先事项。
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1450-8. doi: 10.1164/rccm.201504-0767ST.
6
Non-invasive positive pressure ventilation for central sleep apnoea in adults.成人中枢性睡眠呼吸暂停的无创正压通气。
Cochrane Database Syst Rev. 2022 Oct 24;10(10):CD012889. doi: 10.1002/14651858.CD012889.pub2.
7
Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).持续气道正压通气对中枢性睡眠呼吸暂停的抑制作用及心力衰竭患者无移植生存率:加拿大中枢性睡眠呼吸暂停合并心力衰竭患者持续气道正压通气试验(CANPAP)的事后分析
Circulation. 2007 Jun 26;115(25):3173-80. doi: 10.1161/CIRCULATIONAHA.106.683482. Epub 2007 Jun 11.
8
Nocturnal Cardiac Arrhythmias in Heart Failure With Obstructive and Central Sleep Apnea.伴有阻塞性和中枢性睡眠呼吸暂停的心力衰竭患者的夜间心律失常
Chest. 2024 Dec;166(6):1546-1556. doi: 10.1016/j.chest.2024.08.003. Epub 2024 Aug 20.
9
Adaptive servo-ventilation and sleep quality in treatment emergent central sleep apnea and central sleep apnea in patients with heart disease and preserved ejection fraction.适应性伺服通气治疗新发的中心性睡眠呼吸暂停和射血分数保留的心脏病患者的中心性睡眠呼吸暂停与睡眠质量。
Clin Res Cardiol. 2018 May;107(5):421-429. doi: 10.1007/s00392-018-1203-9. Epub 2018 Jan 25.
10
The effect of successful heart transplant treatment of heart failure on central sleep apnea.心力衰竭成功心脏移植治疗对中枢性睡眠呼吸暂停的影响。
Chest. 2003 Nov;124(5):1675-81. doi: 10.1378/chest.124.5.1675.

引用本文的文献

1
Obstructive Sleep Apnea and Outcomes in Cardiac Surgery: A Systematic Review with Meta-Analytic Synthesis (PROSPERO CRD420251049574).阻塞性睡眠呼吸暂停与心脏手术结局:一项Meta分析的系统评价(国际前瞻性系统评价注册库编号CRD420251049574)
Biomedicines. 2025 Jun 27;13(7):1579. doi: 10.3390/biomedicines13071579.
2
Central sleep apnea: realignment required.中枢性睡眠呼吸暂停:需要重新调整。
J Clin Sleep Med. 2025 Feb 1;21(2):227-228. doi: 10.5664/jcsm.11476.
3
Clinical and PSG Characteristics Comparison of Central Sleep Apnea in the Elderly and Non-Elderly Patients.

本文引用的文献

1
Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence.乙酰唑胺的副作用:一项系统评价和荟萃分析评估总体风险和剂量依赖性。
BMJ Open Respir Res. 2020 Apr;7(1). doi: 10.1136/bmjresp-2020-000557.
2
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.旨在提高阻塞性睡眠呼吸暂停成年人持续气道正压通气机使用情况的教育、支持及行为干预措施。
Cochrane Database Syst Rev. 2020 Apr 7;4(4):CD007736. doi: 10.1002/14651858.CD007736.pub3.
3
A workshop report on the causes and consequences of sleep health disparities.
老年与非老年患者中枢性睡眠呼吸暂停的临床和多导睡眠图特征比较
Nat Sci Sleep. 2024 Nov 1;16:1749-1756. doi: 10.2147/NSS.S489668. eCollection 2024.
4
Obstructive Sleep Apnea after COVID-19: An Observational Study.新冠病毒感染后阻塞性睡眠呼吸暂停:一项观察性研究。
Life (Basel). 2024 Aug 22;14(8):1052. doi: 10.3390/life14081052.
5
Chronic intermittent hypoxia elicits distinct transcriptomic responses among neurons and oligodendrocytes within the brainstem of mice.慢性间歇性低氧会在小鼠脑干的神经元和少突胶质细胞中引发不同的转录组反应。
Am J Physiol Lung Cell Mol Physiol. 2024 Jun 1;326(6):L698-L712. doi: 10.1152/ajplung.00320.2023. Epub 2024 Apr 9.
6
Central sleep apnoea: not just one phenotype.中枢性睡眠呼吸暂停:不仅仅是一种表型。
Eur Respir Rev. 2024 Mar 27;33(171). doi: 10.1183/16000617.0141-2023. Print 2024 Jan 31.
7
Cardiovascular imaging research priorities.心血管影像学研究重点。
Open Heart. 2023 Aug;10(2). doi: 10.1136/openhrt-2023-002378.
8
Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea.在慢性心力衰竭患者中起始使用达格列净可改善中枢性睡眠呼吸暂停。
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00123-2023. eCollection 2023 May.
9
High nocturnal periodic breathing reported by PAP adherence data predicts decompensation of heart failure.夜间周期性呼吸增多通过 PAP 依从性数据预测心力衰竭失代偿。
J Clin Sleep Med. 2023 Mar 1;19(3):431-441. doi: 10.5664/jcsm.10346.
10
Prevalence and predictors of sleep-disordered breathing in chronic heart failure: the SchlaHF-XT registry.慢性心力衰竭患者睡眠呼吸障碍的患病率及其预测因素:SchlaHF-XT 登记研究。
ESC Heart Fail. 2022 Dec;9(6):4100-4111. doi: 10.1002/ehf2.14027. Epub 2022 Sep 2.
睡眠健康差距的原因和后果研讨会报告
Sleep. 2020 Aug 12;43(8). doi: 10.1093/sleep/zsaa037.
4
Effect of acetazolamide on susceptibility to central sleep apnea in chronic spinal cord injury.乙酰唑胺对慢性脊髓损伤患者中枢性睡眠呼吸暂停易感性的影响。
J Appl Physiol (1985). 2020 Apr 1;128(4):960-966. doi: 10.1152/japplphysiol.00532.2019. Epub 2020 Feb 20.
5
Update on Apneas of Heart Failure With Reduced Ejection Fraction: Emphasis on the Physiology of Treatment: Part 2: Central Sleep Apnea.心力衰竭射血分数降低伴呼吸暂停的最新进展:治疗生理学重点:第 2 部分:中枢性睡眠呼吸暂停。
Chest. 2020 Jun;157(6):1637-1646. doi: 10.1016/j.chest.2019.12.020. Epub 2020 Jan 17.
6
Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease.心脏康复对冠心病患者睡眠呼吸暂停严重程度的长期影响。
J Clin Sleep Med. 2020 Jan 15;16(1):65-71. doi: 10.5664/jcsm.8124. Epub 2019 Dec 3.
7
Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial.与 Cheyne-Stokes 呼吸相关的生物特征和机制途径:来自 SERVE-HF 试验的见解。
Clin Res Cardiol. 2020 Jul;109(7):881-891. doi: 10.1007/s00392-019-01578-9. Epub 2019 Nov 29.
8
Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea.膈肌神经刺激治疗中枢性睡眠呼吸暂停的长期疗效和安全性。
Sleep. 2019 Oct 21;42(11). doi: 10.1093/sleep/zsz158.
9
Are sleep patterns influenced by race/ethnicity - a marker of relative advantage or disadvantage? Evidence to date.睡眠模式是否受种族/族裔影响——相对优势或劣势的一个标志?迄今为止的证据。
Nat Sci Sleep. 2019 Jul 23;11:79-95. doi: 10.2147/NSS.S169312. eCollection 2019.
10
Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis.射血分数降低的心力衰竭伴中枢性睡眠呼吸暂停患者的 Cheyne-Stokes 呼吸特征与严重不良事件的相关性:SERVE-心力衰竭子研究分析。
Respirology. 2020 Mar;25(3):305-311. doi: 10.1111/resp.13613. Epub 2019 Jun 20.